We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Geneoscopy Submits Premarket Application for Breakthrough Colorectal Screening Device
Geneoscopy Submits Premarket Application for Breakthrough Colorectal Screening Device
Gastrointestinal diagnostic test developer Geneoscopy has submitted a premarket approval (PMA) application to the FDA for its ColonoSight, a stool-based at-home noninvasive screening test that detects colorectal cancer (CRC) and advanced adenomas (AA) in average-risk individuals.